Connect your AI

Shattuck Labs, Inc. STTK Price / sales

Price / sales at other companies

Eli LillyLLY

11.4×-3.8×

Johnson & JohnsonJNJ

6.1×+1.6×

AmgenAMGN

5.1×+0.2×

AbbVieABBV

6.1×-0.3×

Aclaris TherapeuticsACRS

54.3×+45.0×

Avalo TherapeuticsAVTX

176.3×+173×

Other financials

Income statement

Revenue-—

Operating income-$15.5M-8.0%

Net income-$14.8M-7.8%

EPS (diluted)-$0.13+51.9%

Balance sheet

Cash & equivalents$90.4M+48.5%

Total debt$2.9M-9.5%

Total equity$95.8M+41.8%

Total assets$102.1M+32.3%

Cash flow

Operating cash flow-$13.4M-11.6%

CapEx$63.0K—

Free cash flow-$13.5M-12.1%

Valuation

Market cap$564.45M+1,131%

Enterprise value$476.92M-4,119%

Profitability

Operating margin-5,266.4%-9,520pp

Net margin-4,987.4%-8,966pp

FCF margin-4,140.8%-7,144pp

Returns & leverage

Return on equity-61%-8.0pp

Debt / equity0×0.0×

Current ratio22.1×+13.0×

Where this comes from

Calculated from Shattuck Labs, Inc.’s reported figures.

market cap/total revenue=460.2×

Based on the most recent quarter.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Shattuck Labs, Inc.'s price / sales?: Shattuck Labs, Inc. (STTK) reported price / sales of 460.2× in Q1 2026.
How has Shattuck Labs, Inc.'s price / sales changed year-over-year?: Shattuck Labs, Inc.'s price / sales increased by 4557.3% year-over-year, from 9.9× to 460.2×.
What is the long-term trend for Shattuck Labs, Inc.'s price / sales?: Over 5 years (2020 to 2025), Shattuck Labs, Inc.'s price / sales has grown at a 0.7% compound annual growth rate (CAGR), from 222.9× to 231×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.